Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT

<p>Abstract</p> <p>Background</p> <p>Around 80% of intrauterine growth restricted (IUGR) infants are born at term. They have an increase in perinatal mortality and morbidity including behavioral problems, minor developmental delay and spastic cerebral palsy. Management...

Full description

Bibliographic Details
Main Authors: Huisjes Anjoke JM, van der Salm Paulien CM, Drogtrop Addie P, Ribbert Lucy SM, Bekedam Dick J, van der Post Joris AM, van Meir Claudia A, Bloemenkamp Kitty WM, Stigter Rob H, van Pampus Marielle G, Birnie Erwin, LeCessie Saskia, Mol Ben WJ, Bijlenga Denise, Boers Kim E, Willekes Christine, Roumen Frans JME, Scheepers Hubertina CJ, de Boer Karin, Duvekot Johannes J, Thornton Jim G, Scherjon Sicco A
Format: Article
Language:English
Published: BMC 2007-07-01
Series:BMC Pregnancy and Childbirth
Online Access:http://www.biomedcentral.com/1471-2393/7/12
_version_ 1819117644146540544
author Huisjes Anjoke JM
van der Salm Paulien CM
Drogtrop Addie P
Ribbert Lucy SM
Bekedam Dick J
van der Post Joris AM
van Meir Claudia A
Bloemenkamp Kitty WM
Stigter Rob H
van Pampus Marielle G
Birnie Erwin
LeCessie Saskia
Mol Ben WJ
Bijlenga Denise
Boers Kim E
Willekes Christine
Roumen Frans JME
Scheepers Hubertina CJ
de Boer Karin
Duvekot Johannes J
Thornton Jim G
Scherjon Sicco A
author_facet Huisjes Anjoke JM
van der Salm Paulien CM
Drogtrop Addie P
Ribbert Lucy SM
Bekedam Dick J
van der Post Joris AM
van Meir Claudia A
Bloemenkamp Kitty WM
Stigter Rob H
van Pampus Marielle G
Birnie Erwin
LeCessie Saskia
Mol Ben WJ
Bijlenga Denise
Boers Kim E
Willekes Christine
Roumen Frans JME
Scheepers Hubertina CJ
de Boer Karin
Duvekot Johannes J
Thornton Jim G
Scherjon Sicco A
author_sort Huisjes Anjoke JM
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Around 80% of intrauterine growth restricted (IUGR) infants are born at term. They have an increase in perinatal mortality and morbidity including behavioral problems, minor developmental delay and spastic cerebral palsy. Management is controversial, in particular the decision whether to induce labour or await spontaneous delivery with strict fetal and maternal surveillance. We propose a randomised trial to compare effectiveness, costs and maternal quality of life for induction of labour versus expectant management in women with a suspected IUGR fetus at term.</p> <p>Methods/design</p> <p>The proposed trial is a multi-centre randomised study in pregnant women who are suspected on clinical grounds of having an IUGR child at a gestational age between 36+0 and 41+0 weeks. After informed consent women will be randomly allocated to either induction of labour or expectant management with maternal and fetal monitoring. Randomisation will be web-based. The primary outcome measure will be a composite neonatal morbidity and mortality. Secondary outcomes will be severe maternal morbidity, maternal quality of life and costs. Moreover, we aim to assess neurodevelopmental and neurobehavioral outcome at two years as assessed by a postal enquiry (Child Behavioral Check List-CBCL and Ages and Stages Questionnaire-ASQ). Analysis will be by intention to treat. Quality of life analysis and a preference study will also be performed in the same study population. Health technology assessment with an economic analysis is part of this so called Digitat trial (Disproportionate Intrauterine Growth Intervention Trial At Term). The study aims to include 325 patients per arm.</p> <p>Discussion</p> <p>This trial will provide evidence for which strategy is superior in terms of neonatal and maternal morbidity and mortality, costs and maternal quality of life aspects. This will be the first randomised trial for IUGR at term.</p> <p>Trial registration</p> <p>Dutch Trial Register and ISRCTN-Register: ISRCTN10363217.</p>
first_indexed 2024-12-22T05:36:15Z
format Article
id doaj.art-3c9e49224d2048378700902385919257
institution Directory Open Access Journal
issn 1471-2393
language English
last_indexed 2024-12-22T05:36:15Z
publishDate 2007-07-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj.art-3c9e49224d20483787009023859192572022-12-21T18:37:18ZengBMCBMC Pregnancy and Childbirth1471-23932007-07-01711210.1186/1471-2393-7-12Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITATHuisjes Anjoke JMvan der Salm Paulien CMDrogtrop Addie PRibbert Lucy SMBekedam Dick Jvan der Post Joris AMvan Meir Claudia ABloemenkamp Kitty WMStigter Rob Hvan Pampus Marielle GBirnie ErwinLeCessie SaskiaMol Ben WJBijlenga DeniseBoers Kim EWillekes ChristineRoumen Frans JMEScheepers Hubertina CJde Boer KarinDuvekot Johannes JThornton Jim GScherjon Sicco A<p>Abstract</p> <p>Background</p> <p>Around 80% of intrauterine growth restricted (IUGR) infants are born at term. They have an increase in perinatal mortality and morbidity including behavioral problems, minor developmental delay and spastic cerebral palsy. Management is controversial, in particular the decision whether to induce labour or await spontaneous delivery with strict fetal and maternal surveillance. We propose a randomised trial to compare effectiveness, costs and maternal quality of life for induction of labour versus expectant management in women with a suspected IUGR fetus at term.</p> <p>Methods/design</p> <p>The proposed trial is a multi-centre randomised study in pregnant women who are suspected on clinical grounds of having an IUGR child at a gestational age between 36+0 and 41+0 weeks. After informed consent women will be randomly allocated to either induction of labour or expectant management with maternal and fetal monitoring. Randomisation will be web-based. The primary outcome measure will be a composite neonatal morbidity and mortality. Secondary outcomes will be severe maternal morbidity, maternal quality of life and costs. Moreover, we aim to assess neurodevelopmental and neurobehavioral outcome at two years as assessed by a postal enquiry (Child Behavioral Check List-CBCL and Ages and Stages Questionnaire-ASQ). Analysis will be by intention to treat. Quality of life analysis and a preference study will also be performed in the same study population. Health technology assessment with an economic analysis is part of this so called Digitat trial (Disproportionate Intrauterine Growth Intervention Trial At Term). The study aims to include 325 patients per arm.</p> <p>Discussion</p> <p>This trial will provide evidence for which strategy is superior in terms of neonatal and maternal morbidity and mortality, costs and maternal quality of life aspects. This will be the first randomised trial for IUGR at term.</p> <p>Trial registration</p> <p>Dutch Trial Register and ISRCTN-Register: ISRCTN10363217.</p>http://www.biomedcentral.com/1471-2393/7/12
spellingShingle Huisjes Anjoke JM
van der Salm Paulien CM
Drogtrop Addie P
Ribbert Lucy SM
Bekedam Dick J
van der Post Joris AM
van Meir Claudia A
Bloemenkamp Kitty WM
Stigter Rob H
van Pampus Marielle G
Birnie Erwin
LeCessie Saskia
Mol Ben WJ
Bijlenga Denise
Boers Kim E
Willekes Christine
Roumen Frans JME
Scheepers Hubertina CJ
de Boer Karin
Duvekot Johannes J
Thornton Jim G
Scherjon Sicco A
Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT
BMC Pregnancy and Childbirth
title Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT
title_full Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT
title_fullStr Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT
title_full_unstemmed Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT
title_short Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT
title_sort disproportionate intrauterine growth intervention trial at term digitat
url http://www.biomedcentral.com/1471-2393/7/12
work_keys_str_mv AT huisjesanjokejm disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT vandersalmpauliencm disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT drogtropaddiep disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT ribbertlucysm disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT bekedamdickj disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT vanderpostjorisam disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT vanmeirclaudiaa disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT bloemenkampkittywm disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT stigterrobh disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT vanpampusmarielleg disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT birnieerwin disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT lecessiesaskia disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT molbenwj disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT bijlengadenise disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT boerskime disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT willekeschristine disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT roumenfransjme disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT scheepershubertinacj disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT deboerkarin disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT duvekotjohannesj disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT thorntonjimg disproportionateintrauterinegrowthinterventiontrialattermdigitat
AT scherjonsiccoa disproportionateintrauterinegrowthinterventiontrialattermdigitat